Correction to: The Effect of Rifampin on the Pharmacokinetics and Safety of Lorlatinib: Results of a Phase One, Open-Label, Crossover Study in Healthy Participants.
Journal
Advances in therapy
ISSN: 1865-8652
Titre abrégé: Adv Ther
Pays: United States
ID NLM: 8611864
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
pubmed:
11
9
2020
medline:
11
9
2020
entrez:
10
9
2020
Statut:
ppublish
Résumé
In the original article, the reference 4 has been published and cited incorrectly.
Identifiants
pubmed: 32910418
doi: 10.1007/s12325-020-01480-1
pii: 10.1007/s12325-020-01480-1
doi:
Types de publication
Published Erratum
Langues
eng
Pagination
4754Commentaires et corrections
Type : ErratumFor